Evidence map›Paper›PMID 42865306›Full record

ArticlePediatrics international : official journal of the Japan Pediatric Society

Risk Interval of Immune Thrombocytopenia in Children After Influenza Infection.

Kyosuke Ibi, Yoshihisa Miyamoto, Motohiro Kato, Hideo Yasunaga

Abstract read
In one paragraph

Article in Pediatrics international : official journal of the Japan Pediatric Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kyosuke IbiDepartment of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID https://orcid.org/0000-0002-2258-054X
Yoshihisa MiyamotoDepartment of Clinical Epidemiology and Health Economics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID https://orcid.org/0000-0003-2852-2946
Motohiro KatoDepartment of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID https://orcid.org/0000-0001-5145-1774
Hideo YasunagaDepartment of Clinical Epidemiology and Health Economics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID https://orcid.org/0000-0002-6017-469X

Funding

The Ministry of Health, Labour and Welfare, Japan 26AA2006
6 · The paper itself

Abstract

backgroundThe temporal association between influenza and immune thrombocytopenia (ITP) is poorly characterized. This study examined the risk interval between influenza infection and newly diagnosed ITP in children.

methodsWe enrolled individuals aged 1-15 years newly diagnosed with ITP between 2005 and 2024, using the Japanese large-scale administrative JMDC Database. We conducted a nested case-control study and self-controlled case series to evaluate the risk of ITP within 28 days (categorized into 7-day intervals) of influenza diagnosis. We estimated the risk interval from influenza diagnosis to ITP onset using conditional logistic and Poisson regressions.

resultsWe identified 2255 individuals diagnosed with ITP, of whom 1324 met the eligibility criteria. In the nested case-control analysis, the adjusted odds ratio of preceding influenza diagnosis was the highest within 1-7 days before ITP onset (3.13; 95% confidence interval 1.38-7.12) compared with the matched controls. In the self-controlled case series, the incidence rate ratio for ITP was the highest within 1-7 days after influenza diagnosis compared to the baseline period (2.44; 95% confidence interval 1.16-5.14). In the sensitivity and post hoc analyses for different definitions of influenza diagnosis and ITP onset dates, ITP onset peaked within 1-14 days of influenza diagnosis.

conclusionsThe risk of ITP appeared to be highest during the first 1-2 weeks after influenza diagnosis, particularly around the first week.

Indexed as

Influenza, HumanPurpura, Thrombocytopenic, IdiopathicAdolescentCase-Control StudiesChildChild, PreschoolFemaleHumansIncidenceInfantJapanMaleRisk FactorsTime Factorsepidemiologyimmune thrombocytopeniaimmune thrombocytopenic purpuraimmunologyinfluenza

Identifiers

PMID42865306
PMCPMC13659412

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.